TY - JOUR
T1 - Estimation of cardiac reserve by peak power
T2 - Validation and initial application of a simplified index
AU - Armstrong, G. P.
AU - Carlier, S. G.
AU - Fukamachi, K.
AU - Thomas, J. D.
AU - Marwick, T. H.
PY - 1999
Y1 - 1999
N2 - Objectives - To validate a simplified estimate of peak power (SPP) against true (invasively measured) peak instantaneous power (TPP), to assess the feasibility of measuring SPP during exercise and to correlate this with functional capacity. Design - Development of a simplified method of measurement and observational study. Setting - Tertiary referral centre for cardiothoracic disease. Subjects - For validation of SPP with TPP, seven normal dogs and four dogs with dilated cardiomyopathy were studied. To assess feasibility and clinical significance in humans, 40 subjects were studied (26 patients; 14 normal controls). Methods - In the animal validation study, TPP was derived from ascending aortic pressure and flow probe, and from Doppler measurements of flow. SPP, calculated using the different flow measures, was compared with peak instantaneous power under different loading conditions. For the assessment in humans, SPP was measured at rest and during maximum exercise. Peak aortic flow was measured with transthoracic continuous wave Doppler, and systolic and diastolic blood pressures were derived from brachial sphygmomanometry. The difference between exercise and rest simplified peak power (Δ SPP) was compared with maximum oxygen uptake (VO2max), measured from expired gas analysis. Results - SPP estimates using peak flow measures correlated well with true peak instantaneous power (r = 0.89 to 0.97), despite marked changes in systemic pressure and flow induced by manipulation of loading conditions. In the human study, VO2max correlated with Δ SPP (r = 0.78) better than Δ ejection fraction (r = 0.18) and Δ rate-pressure product (r = 0.59). Conclusions - The simple product of mean arterial pressure and peak aortic flow (simplified peak power, SPP) correlates with peak instantaneous power over a range of loading conditions in dogs. In humans, it can be estimated during exercise echocardiography, and correlates with maximum oxygen uptake better than ejection fraction or rate-pressure product.
AB - Objectives - To validate a simplified estimate of peak power (SPP) against true (invasively measured) peak instantaneous power (TPP), to assess the feasibility of measuring SPP during exercise and to correlate this with functional capacity. Design - Development of a simplified method of measurement and observational study. Setting - Tertiary referral centre for cardiothoracic disease. Subjects - For validation of SPP with TPP, seven normal dogs and four dogs with dilated cardiomyopathy were studied. To assess feasibility and clinical significance in humans, 40 subjects were studied (26 patients; 14 normal controls). Methods - In the animal validation study, TPP was derived from ascending aortic pressure and flow probe, and from Doppler measurements of flow. SPP, calculated using the different flow measures, was compared with peak instantaneous power under different loading conditions. For the assessment in humans, SPP was measured at rest and during maximum exercise. Peak aortic flow was measured with transthoracic continuous wave Doppler, and systolic and diastolic blood pressures were derived from brachial sphygmomanometry. The difference between exercise and rest simplified peak power (Δ SPP) was compared with maximum oxygen uptake (VO2max), measured from expired gas analysis. Results - SPP estimates using peak flow measures correlated well with true peak instantaneous power (r = 0.89 to 0.97), despite marked changes in systemic pressure and flow induced by manipulation of loading conditions. In the human study, VO2max correlated with Δ SPP (r = 0.78) better than Δ ejection fraction (r = 0.18) and Δ rate-pressure product (r = 0.59). Conclusions - The simple product of mean arterial pressure and peak aortic flow (simplified peak power, SPP) correlates with peak instantaneous power over a range of loading conditions in dogs. In humans, it can be estimated during exercise echocardiography, and correlates with maximum oxygen uptake better than ejection fraction or rate-pressure product.
KW - Cardiac power output
KW - Left ventricular function
KW - Oxygen consumption
KW - Stress echocardiography
UR - http://www.scopus.com/inward/record.url?scp=0032823139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032823139&partnerID=8YFLogxK
U2 - 10.1136/hrt.82.3.357
DO - 10.1136/hrt.82.3.357
M3 - Article
C2 - 10455090
AN - SCOPUS:0032823139
SN - 1355-6037
VL - 82
SP - 357
EP - 364
JO - Heart
JF - Heart
IS - 3
ER -